Channel Medsystems Announces First Endometrial Ablation Procedures in Europe with the Cerene® Cryotherapy Device BERKELEY, Calif., DATE – Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first procedures in Europe were performed with the Cerene® Cryotherapy Device for […]
MENLO PARK, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives today announced Clinical Ophthalmology has published data from a subgroup analysis of the OLYMPIA trial, which showed a single treatment with the TearCare System
HAYWARD, Calif., Sept. 13, 2022 – Potrero Medical announced today that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, for the advanced prediction of acute kidney injury (AKI) associated with intra-abdominal hypertension (IAH) in cardiac post-surgical intensive care patients. “We are excited about the designation, and what this means for patients, providers
MENLO PARK, Calif., August 23, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives, today announced the launch of SION, a surgical instrument representing a new chapter in goniotomy innovation and practice. Sight Sciences is a
MENLO PARK, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives, today announced 36-month post-surgery follow-up results of the OMNI® Surgical System. The data demonstrates that the OMNI Surgical System delivers safe, consistent,
MENLO PARK, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today reported financial results for the second quarter ended June 30, 2022. Recent Business Highlights Generated total revenue of $17.2 million in the second
Sight Sciences Reports Second Quarter 2022 Financial Results Read More »
Channel Medsystems Announces Publication of Long-term Clinical Outcomes with Cerene® Cryotherapy for the Treatment of Heavy Menstrual Bleeding Cerene Cryotherapy is clinically proven to significantly reduce menstrual bleeding and premenstrual symptoms safely and effectively with high patient satisfaction through 36 months following treatment BERKELEY, Calif.–(BUSINESS WIRE)–Channel Medsystems, Inc., a medical device company whose mission is
Long-term Clinical Outcomes with Cerene Cryotherapy Read More »
Berkeley, California August 3, 2022 Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that Heather Knight has joined the company’s Board of Directors. “We are pleased to welcome Heather to our Board of Directors,” said Chief Executive Officer Ric Cote. “Heather
Heather Knight Joins Channel Medsystems Board of Directors Read More »
Mind.Px provides clinically actionable information to physicians prior to treatment choice that significantly reduces “trial and error” biologic drug prescribing behavior, leading to improved psoriasis patient outcomes and reductions in wasted spending SAN DIEGO, CA – July 26, 2022 – Mindera Health announces the publication, in the Journal of Drugs in Dermatology, of the
MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced the appointment of Tamara Fountain, M.D. to its Board of Directors, effective July 15, 2022. As part of her duties, Dr. Fountain